Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02248311 : "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
PhaseN/A
AgesMin: 50 Years Max: 79 Years
Eligibility
Inclusion Criteria:

- a) Age from 50-79 years; b) History of type 2diabetes of at least one year. Diabetes
will be defined following the American Diabetic Association criteria: fasting glucose
level of at least 126 mg/dl [7.0 mmol/l] in two separate analyses, a non-fasting
glucose level of at least 200 mg/dl [11.1 mmol/l] or a self-reported history of
physician-diagnosed diabetes or treatment for diabetes

Exclusion Criteria:

- a) Past medical history of Cardiovascular event; b) Type 1 diabetes; c)
Contraindication for PET-CT or MRI d) Other concomitant disease associated with a
short life expectancy
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02248311      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740